Patients reporting of suspected adverse reactions to antidepressants. A pilot methodological study

Farmacia

Volumn 58, Issue 3, 2010, Pages 255-263

  Farcas, Andreea Maria ^a   Farah, Camelia ^a   Bojita, Marius Traian ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Adverse effects; Antidepressants; Patients reporting

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CENTRAL STIMULANT AGENT; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; OLANZAPINE; PAROXETINE; QUETIAPINE; SERTRALINE; VENLAFAXINE;

ADULT; ADVERSE DRUG REACTION; AGED; AGGRESSION; AMNESIA; ANXIETY; ARTICLE; BIPOLAR DISORDER; CONFUSION; DEPRESSION; DIZZINESS; DRUG INDUCED HEADACHE; DRUG USE; FATIGUE; FEASIBILITY STUDY; FEMALE; HEALTH CARE PERSONNEL; HUMAN; HYPERHIDROSIS; INCREASED APPETITE; INSOMNIA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL CONCENTRATION; NIGHTMARE; PANIC; PARESTHESIA; PHARMACY; PILOT STUDY; QUESTIONNAIRE; SELF REPORT; SEXUAL DYSFUNCTION; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; SUICIDAL IDEATION; TREMOR; WEIGHT GAIN; XEROSTOMIA;

EID: 77953877617     PISSN: 00148237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Harmark L., van Grootheest A.C., Pharmacovigilance: methods, recent developments and future perspectives. Eur J Clin Pharmacol, 2008, 64, 743-752.
2. Hazell L., Shakir S.A.W., Under-Reporting of Adverse Drug Reactions. A Systematic Review, Drug Saf, 2006, 29(5), 385-396.
3. Van Grootheest K., de Graaf L., de Jong-van den Berg L., Consumer Adverse Drug Reaction Reporting. A New Step in Pharmacovigilance? Drug Saf, 2003, 26(4), 211-217. (Pubitemid 36363604)
4. Van Grootheest K., de Jong-van den Berg L., Patients' role in reporting adverse drug reactions, Expert Opin Drug Saf, 2004, 3(4), 363-368.
5. Blekinsopp A., Wilkie P., Wang M., Routledge P.A., Patient reporting of suspected adverse drug reactions: a review of published literature and international experience, Br J Clin Pharmacol, 2006, 63(2), 148-156.
6. de Langen J., van Hunsel F., Passier A., de Jong-van den Berg L., van Grootheest K., Adverse Drug Reaction Reporting by Patients in the Netherlands. Three Years of Experience, Drug Saf, 2008, 31(6), 515-524.
7. Agentia Nationalǎ a Medicamentului. Buletin informativ 2008, An. 10, Nr. 1(37), trim. I. HOTǍRÂREA Nr. 24/28.09.2007 referitoare la aprobarea Ghidului privind procedura care trebuie urmatǎ de cǎtre autoritǎţile competente în desfǎşurarea activitǎţii de farmacovigilenţǎ.
8. Farcaş A., Macavei C., Bojiţǎ M., Physicians' attitude towards voluntary reporting of adverse drug reactions., Farmacia, 2008, 56(5): 563-570.
9. van Geffen E.C.G., van de Wal S.W., van Hulten R., van Groot M.C.H., Egberts A.C.G., Heerdink E.R., Evaluation of patients' experiences with antidepressants reported by means of a medicine reporting system., Eur J Clin Pharmacol, 2007, 63, 1193-1199.
10. Stewart D., Helms P., McCraig D., Bond C., McLay J., Monitoring adverse drug reactions in children using community pharmacies: a pilot study, Br J Clin Pharmacol, 2005, 59(6), 677-683.
11. Jarernsiripornkul N., Krska J., Capps P.A.G., Richards R.M.E., Lee A., Patient reporting of potential adverse drug reactions: a methodological study, Br J Clin Pharmacol, 2002, 53, 318-325.